Results 61 to 70 of about 15,817 (194)

Experience of entecavir therapy in chronic hepatitis B

Журнал инфектологии, 2014
Entecavir is a potent and selective guanosine analogue that has demonstrated a significant antiviral efficacy against hepatitis B virus. The purpose of this article was to characterize the response to entecavir and it portability.
E. V. Esaulenko, J. S. Alikjan, O. Y. Emelyanjva, T. A. Stasishkis, A. Y. Kovelenov   +4 more
doaj   +1 more source

Comparison Between Entecavir and Lamivudine as Hepatitis B Reactivation Prophylaxis in Cancer Patient with Chemotherapy [PDF]

, 2015
Aim: to compare between entecavir and lamivudine as hepatitis B reactivation prophylaxis in cancer patient with chemotherapyMethod: a literature searching in PubMed was done. At the beginning, 8 articles were found. Chosen article in this EBCR were those
Dharaniyadewi, D. (Dana), Hamonangan, R. (Rachmat), Siregar, N. N. (Nia)   +2 more
core  

Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral Therapy

Journal of Medical Virology, Volume 98, Issue 3, March 2026.
ABSTRACT Background and Aim Chronic hepatitis B (CHB) affects over 250 million people globally and is a major contributor to liver complications, including cirrhosis and hepatocellular carcinoma (HCC). Though antiviral therapies suppress HBV, the rising prevalence of metabolic‐associated steatotic liver disease (MASLD) poses new challenges.
Sheng‐Jie Shiue, Tung‐Han Ho, Hsin‐Yi Lin, Sheng‐Wei Cheng, Li‐Wei Wu, Tze‐Sian Chan, Chun‐Nan Chen, Chao‐Ling Cheng, Yan Kang Lee, Hsien‐Yao Yang, Han‐Shiang Shiue, Kuo‐Feng Leng, Ming‐Shun Wu   +12 more
wiley   +1 more source

Identification of hepatitis B virus DNA reverse transcriptase variants associated with partial response to entecavir [PDF]

, 2015
published_or_final_versio
Fung, JYY, Lai, CL, Wong, DKH, Yuen, RMF
core  

Future prevention and treatment of chronic hepatitis B infection [PDF]

, 2012
Vaccination for hepatitis B virus (HBV) infection and treatment for chronic hepatitis B, while effective for primary prevention and control of the disease, still have their limitations. Global coverage of HBV immunization needs improvement.
Fung, J, Lai, CL, Seto, WK, Yuen, MF
core   +1 more source

Meta‐Analysis: High anti‐HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 5, Page 592-602, March 2026.
This meta‐analysis demonstrates a significantly lower risk for HBV reactivation on rituximab if anti‐HBs is > 100 iU/L (3.5%, CI: 1.8%–6.9%) vs. anti‐HBs between 10 and 100 iU/L (13.8%, CI: 8.8%–20.8%) and anti‐HBs negative (27.3%, CI: 20.0%–36.0%). Thus, if anti‐HBs titer is > 10 iU/L, monitoring could be considered.
Shiva Poola, MaryKate Kratzer, Kerry Sewell, Zikun Yang, Hans L. Tillmann   +4 more
wiley   +1 more source

Clinical utility of entecavir for chronic hepatitis B in Chinese patients

Drug Design, Development and Therapy, 2013
Jiyao WangZhongshan Hospital, Fudan University, Shanghai, Key Laboratory of Medical Molecular Virology of MOE/MOH, Shanghai, People’s Republic of ChinaAbstract: The People’s Republic of China has one of the highest rates of hepatitis B virus (
Wang JY
doaj  

Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management [PDF]

, 2017
Hepatitis B virus (HBV) reactivation during or after chemotherapy in patients with breast cancer has become a remarkable clinical problem. Prophylactic nucleos(t)ide analogues (NAs) are recommended for patients with breast cancer who are hepatitis B ...
Gong, Chang, Jiang, L., Jiang, Wen, Liang, G., Liu, Z, Song, E., Zheng, Y   +6 more
core   +2 more sources

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies

European Journal of Haematology, Volume 116, Issue 3, Page 204-214, March 2026.
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

The Contingent Payoff of Transparency: The Mediating Roles of Citizen Participation and Enforcement in Health Service Delivery Improvement

Journal of Evaluation in Clinical Practice, Volume 32, Issue 2, March 2026.
ABSTRACT Background How transparency reforms affect frontline health service delivery remains uncertain. Research presents a transparency paradox, where some studies report service improvements when transparency is combined with oversight, while others find minimal impact on outcomes such as staff absence or medicine availability.
Samuel Atiku, Alfred Okoh, Olufisayo Olakotan   +2 more
wiley   +1 more source